Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Promega

Promega
1978 FOUNDED
PRIVATE STATUS
1K-5K EMPLOYEES
Repurchase LATEST DEAL TYPE
6 FINANCING ROUNDS
2 INVESTMENTS
Description

Provider of technology and technical support to the life sciences industry. The company's products include automation-robotics, PCR cloning technology, DNA and RNA purification systems, buffers and reagents, cloning and restriction enzymes, and food and GMO testing tools. It also offers electrophoresis, gene expression and reporter assay, mutagenesis, protein interaction, protein expression and analysis, RNA interference, transfection, genetic identity, apoptosis, cell viability, drug discovery, immunological detection, in vitro toxicology and signal-transduction products.

Website
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Primary Office
  • 2800 Woods Hollow Road
  • Madison, WI 53711
  • United States

+1 (608) 000-0000

Promega Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Promega‘s full profile, request access.

Request full access to PitchBook

Promega Competitors (52)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Caris Life Sciences Private Equity-Backed Irving, TX 000 00000 000000000 00000
00000000 0000 0000 Private Equity-Backed Milford, MA 000 000000000000
00000 Formerly VC-backed San Carlos, CA 00 000.00 000000&0 000.00
000000000 00000000 Formerly VC-backed Billerica, MA 00 00000 000000&0 00000
00000 0000000000 Formerly VC-backed San Francisco, CA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Promega Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000000 03-Aug-2009 000000000000000000 Electrical Equipment 0000000 000000
Benitec Biopharma 08-Oct-2007 PIPE 00000 Drug Discovery 0000000 000000
To view this company’s complete investment and acquisition history, request access »

Promega Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Promega‘s full profile, request access.

Request full access to PitchBook

Promega Executive Team (9)

Name Title Board
Seat
Contact
Info
William Linton Founder, Chairman & Chief Executive Officer
Randall Dimond Ph.D Chief Technology Officer & Vice President
Martin Rosenberg Ph.D Chief Scientific Officer
Janet White Director, Cell Analysis & Proteomics

5 Former Executives

You’re viewing 4 of 9 executives. Get the full list »

Promega Board Members (3)

Name Representing Role Since Contact
Info
00000 0000 Self Board Member 000 0000
0000000 000000 Promega Founder, Chairman & Chief Executive Officer 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »